AI Tokens
Stock Analysis on Net

Monsanto Co. (NYSE:MON)

This company has been moved to the archive! The financial data has not been updated since April 5, 2018.

Common-Size Income Statement
Quarterly Data

Monsanto Co., common-size consolidated income statement (quarterly data)

Microsoft Excel
3 months ended: Feb 28, 2018 Nov 30, 2017 Aug 31, 2017 May 31, 2017 Feb 28, 2017 Nov 30, 2016 Aug 31, 2016 May 31, 2016 Feb 29, 2016 Nov 30, 2015 Aug 31, 2015 May 31, 2015 Feb 28, 2015 Nov 30, 2014 Aug 31, 2014 May 31, 2014 Feb 28, 2014 Nov 30, 2013 Aug 31, 2013 May 31, 2013 Feb 28, 2013 Nov 30, 2012 Aug 31, 2012 May 31, 2012 Feb 29, 2012 Nov 30, 2011
Net sales 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost of goods sold -40.90 -50.64 -50.11 -43.59 -41.82 -52.49 -55.58 -43.18 -42.67 -59.40 -57.71 -40.25 -41.52 -50.84 -53.12 -45.15 -40.90 -50.27 -58.04 -46.75 -43.90 -52.47 -58.01 -43.99 -43.03 -55.06
Gross profit 59.10% 49.36% 49.89% 56.41% 58.18% 47.51% 44.42% 56.82% 57.33% 40.60% 42.29% 59.75% 58.48% 49.16% 46.88% 54.85% 59.10% 49.73% 41.96% 53.25% 56.10% 47.53% 41.99% 56.01% 56.97% 44.94%
Selling, general and administrative expenses -12.99 -24.98 -34.92 -18.65 -12.95 -22.08 -38.06 -17.40 -12.93 -24.47 -31.46 -15.68 -12.45 -20.21 -34.41 -15.41 -10.72 -18.74 -35.33 -14.88 -10.93 -18.44 -33.79 -15.12 -11.44 -20.50
Research and development expenses -7.85 -14.37 -16.34 -9.86 -7.51 -13.96 -16.43 -9.24 -7.50 -16.40 -17.92 -8.17 -7.16 -14.36 -18.44 -10.05 -6.93 -13.01 -19.75 -9.23 -6.58 -11.77 -20.88 -8.89 -7.43 -14.39
Restructuring charges 0.02 -0.15 0.22 0.40 -0.45 1.36 -0.27 -0.36 -0.20 -11.99 -16.69 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.48 0.00 0.00 0.00
Pending Bayer transaction related costs -0.50 -0.75 -1.19 -0.78 -0.53 -3.51 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating expenses -21.32% -40.26% -52.23% -28.89% -21.44% -38.19% -54.76% -27.00% -20.63% -52.86% -66.07% -23.85% -19.61% -34.56% -52.85% -25.46% -17.64% -31.75% -55.09% -24.11% -17.51% -30.21% -54.19% -24.01% -18.87% -34.89%
Income (loss) from operations 37.78% 9.10% -2.35% 27.52% 36.74% 9.32% -10.34% 29.82% 36.69% -12.26% -23.78% 35.90% 38.87% 14.60% -5.97% 29.39% 41.46% 17.98% -13.12% 29.14% 38.60% 17.32% -12.20% 32.00% 38.10% 10.05%
Interest expense -2.09 -4.67 -4.24 -2.36 -2.01 -5.13 -4.06 -2.39 -2.27 -5.81 -5.52 -2.10 -1.77 -4.01 -4.30 -0.99 -0.69 -1.69 -2.23 -0.87 -0.64 -1.74 -2.48 -0.92 -0.99 -2.17
Interest income 0.48 0.56 0.86 0.40 0.35 0.68 0.90 0.33 0.38 0.90 0.89 0.39 0.54 1.32 1.44 0.40 0.39 0.76 1.04 0.45 0.49 0.78 0.86 0.50 0.42 0.74
Other income (expense), net 0.48 3.65 0.34 -0.09 1.73 -1.62 5.39 0.84 -3.75 -1.13 -0.64 -0.22 0.12 -0.52 -0.68 -0.07 -1.05 -0.64 -1.18 0.09 -0.40 -0.58 0.00 -0.07 -0.78 -0.25
Income (loss) from continuing operations before income taxes 36.64% 8.65% -5.40% 25.46% 36.82% 3.25% -8.12% 28.60% 31.05% -18.30% -29.04% 33.98% 37.75% 11.39% -9.51% 28.73% 40.12% 16.42% -15.49% 28.81% 38.05% 15.79% -13.82% 31.50% 36.75% 8.36%
Income tax (provision) benefit -7.59 -2.26 6.33 -5.44 -9.95 -2.30 0.04 -11.53 -7.72 6.17 7.94 -8.76 -10.58 -3.48 3.31 -8.02 -11.52 -4.84 4.63 -6.87 -11.02 -4.15 3.34 -8.56 -11.37 -2.87
Income (loss) from continuing operations including portion attributable to noncontrolling interest 29.05% 6.40% 0.93% 20.02% 26.86% 0.94% -8.08% 17.07% 23.32% -12.12% -21.10% 25.22% 27.17% 7.91% -6.20% 20.71% 28.60% 11.58% -10.85% 21.94% 27.03% 11.64% -10.49% 22.94% 25.38% 5.49%
Income (loss) from discontinued operations 0.04 0.04 0.00 0.00 0.06 0.38 0.08 0.00 0.07 0.54 0.21 0.00 0.13 0.56 0.00 0.00 0.07 0.29 0.00 0.00 0.07 0.24 0.05 -0.05 0.15 0.00
Net income (loss) 29.09% 6.43% 0.93% 20.02% 26.92% 1.32% -8.00% 17.07% 23.39% -11.58% -20.89% 25.22% 27.30% 8.47% -6.20% 20.71% 28.67% 11.87% -10.85% 21.94% 27.10% 11.87% -10.44% 22.90% 25.53% 5.49%
Net (income) loss attributable to noncontrolling interest -0.02 -0.08 -0.19 -0.09 0.04 -0.23 0.55 0.05 0.07 0.18 -0.13 -0.31 0.12 0.00 0.27 -0.52 -0.03 -0.16 -0.45 -0.54 0.00 -0.34 -0.48 -0.69 -0.02 -0.33
Net income (loss) attributable to Monsanto Company 29.07% 6.36% 0.74% 19.93% 26.96% 1.09% -7.46% 17.12% 23.46% -11.40% -21.02% 24.92% 27.42% 8.47% -5.93% 20.19% 28.64% 11.71% -11.31% 21.40% 27.10% 11.53% -10.92% 22.21% 25.51% 5.17%

Based on: 10-Q (reporting date: 2018-02-28), 10-Q (reporting date: 2017-11-30), 10-K (reporting date: 2017-08-31), 10-Q (reporting date: 2017-05-31), 10-Q (reporting date: 2017-02-28), 10-Q (reporting date: 2016-11-30), 10-K (reporting date: 2016-08-31), 10-Q (reporting date: 2016-05-31), 10-Q (reporting date: 2016-02-29), 10-Q (reporting date: 2015-11-30), 10-K (reporting date: 2015-08-31), 10-Q (reporting date: 2015-05-31), 10-Q (reporting date: 2015-02-28), 10-Q (reporting date: 2014-11-30), 10-K (reporting date: 2014-08-31), 10-Q (reporting date: 2014-05-31), 10-Q (reporting date: 2014-02-28), 10-Q (reporting date: 2013-11-30), 10-K (reporting date: 2013-08-31), 10-Q (reporting date: 2013-05-31), 10-Q (reporting date: 2013-02-28), 10-Q (reporting date: 2012-11-30), 10-K (reporting date: 2012-08-31), 10-Q (reporting date: 2012-05-31), 10-Q (reporting date: 2012-02-29), 10-Q (reporting date: 2011-11-30).


The common-size income statement reveals a high degree of seasonality and significant volatility in operational margins over the analyzed period. Profitability metrics exhibit a recurring cyclical pattern, with substantial fluctuations in cost of goods sold and operating expenses that lead to alternating periods of high profitability and operational losses.

Gross Profit Trends
Gross profit margins demonstrate a consistent seasonal swing. Peak margins frequently exceed 55% during the February and May quarters, while troughs typically occur in August and November, where margins often drop to the 40% to 45% range. This suggests a recurring cycle in production costs or sales pricing that aligns with specific quarters of the fiscal year.
Operating Expense Analysis
Selling, general and administrative (SG&A) expenses and research and development (R&D) costs both show acute seasonality. SG&A expenses peak significantly in August of most years, often exceeding 30% of net sales, compared to lows of approximately 11% in February. Similarly, R&D expenses generally spike in August, frequently reaching 16% to 20% of net sales, while falling to approximately 6% to 7% in February. These concentrated expenditures contribute heavily to the periodic contraction of operating margins.
Operating Income Volatility
Income from operations is characterized by extreme variance, ranging from peaks above 41% of net sales to deficits exceeding 23%. The losses are most pronounced in the August and November quarters, coinciding with the peaks in COGS and SG&A. The most severe operational decline is observed in August 2015, where operating income fell to -23.78%, driven by a combination of high operating expenses and substantial restructuring charges.
Non-Recurring Charges and Transaction Costs
The latter portion of the analyzed period is marked by specific non-recurring impacts. Restructuring charges became prominent in 2015, with a significant hit of -16.69% in August 2015. Additionally, costs related to the Bayer transaction began appearing in November 2016 and persisted through February 2018, typically ranging from -0.50% to -3.51% of net sales, creating a persistent drag on operating results during those intervals.
Net Income and Bottom-Line Performance
Net income closely mirrors the volatility of operating income. The company achieves its strongest net margins in February, with peaks reaching approximately 29%. Conversely, the bottom line frequently turns negative during the August and November periods. Despite these swings, a recovery is evident by February 2018, with net income attributable to the company returning to a high of 29.07% of net sales.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?